Prostatype Genomics AB (PROGEN) — Free Cash Flow Generation Index
Latest as of June 2020:
0.94x
Prostatype Genomics AB (PROGEN) has a Free Cash Flow Generation Index of 0.94x as of June 2020. Free cash flow of Skr5.27 Million represents 1% of operating cash flow (Skr5.63 Million). See how liquid is Prostatype Genomics AB's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
0.94x
Free Cash Flow / Operating CF
Free Cash Flow
Skr5.27 Million
SEK
Operating Cash Flow
Skr5.63 Million
SEK
Capital Expenditures
Skr361.71K
SEK
Annual Free Cash Flow Generation for Prostatype Genomics AB (None–None)
Year-by-year Free Cash Flow Generation Index for Prostatype Genomics AB. For the full company profile including market capitalisation, see Prostatype Genomics AB (PROGEN) total market value.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).